{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T16:16:37Z","timestamp":1667924197537},"reference-count":45,"publisher":"Media Sphere Publishing Group","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2019]]},"DOI":"10.17116\/jnevro2019119051154","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T13:21:31Z","timestamp":1563369691000},"page":"154","source":"Crossref","is-referenced-by-count":1,"title":["Agomelatine in the treatment of major depressive disorder: assessment of the efficacy and tolerability"],"prefix":"10.17116","volume":"119","author":[{"given":"N. V.","family":"Filippova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. B.","family":"Barylnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Shuldyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2019119051154-1","unstructured":"EMA Valdoxan (Agomelatine). Summary of product characteristics. 2008."},{"key":"key-10.17116\/jnevro2019119051154-2","unstructured":"Kennedy S, Eisfeld B. Agomelatine and its therapeutic potential in the depressed patient. Neuropsych Dis Treat. 2007;3:423-428."},{"key":"key-10.17116\/jnevro2019119051154-3","doi-asserted-by":"publisher","DOI":"10.1021\/ja01543a060"},{"key":"key-10.17116\/jnevro2019119051154-4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-4-768"},{"key":"key-10.17116\/jnevro2019119051154-5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2004.06.004"},{"key":"key-10.17116\/jnevro2019119051154-6","doi-asserted-by":"publisher","DOI":"10.2165\/11318640-000000000-00000"},{"key":"key-10.17116\/jnevro2019119051154-7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1888"},{"key":"key-10.17116\/jnevro2019119051154-8","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20110809-01"},{"key":"key-10.17116\/jnevro2019119051154-9","doi-asserted-by":"publisher","DOI":"10.2165\/11534420-000000000-00000"},{"key":"key-10.17116\/jnevro2019119051154-10","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3140"},{"key":"key-10.17116\/jnevro2019119051154-11","doi-asserted-by":"publisher","DOI":"10.1177\/1359786810372979"},{"key":"key-10.17116\/jnevro2019119051154-12","doi-asserted-by":"publisher","DOI":"10.1177\/1359786810372978"},{"key":"key-10.17116\/jnevro2019119051154-13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60095-0"},{"key":"key-10.17116\/jnevro2019119051154-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.04.002"},{"key":"key-10.17116\/jnevro2019119051154-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.004"},{"key":"key-10.17116\/jnevro2019119051154-16","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.120196"},{"key":"key-10.17116\/jnevro2019119051154-17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60046-5"},{"key":"key-10.17116\/jnevro2019119051154-18","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0267-6"},{"key":"key-10.17116\/jnevro2019119051154-19","unstructured":"Frolova VI. Overview of the network meta-analysis of the effectiveness of antidepressants new generation. Psikhiatriya i Psikhofarmakoterapiya. 2016;18(6):21-25. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119051154-20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008851"},{"key":"key-10.17116\/jnevro2019119051154-21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1353156"},{"key":"key-10.17116\/jnevro2019119051154-22","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000094"},{"key":"key-10.17116\/jnevro2019119051154-23","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X12999140619122914"},{"key":"key-10.17116\/jnevro2019119051154-24","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.051797"},{"key":"key-10.17116\/jnevro2019119051154-25","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318172b48c"},{"key":"key-10.17116\/jnevro2019119051154-26","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v68n1112"},{"key":"key-10.17116\/jnevro2019119051154-27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05347blu"},{"key":"key-10.17116\/jnevro2019119051154-28","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328349b117"},{"key":"key-10.17116\/jnevro2019119051154-29","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m08250"},{"key":"key-10.17116\/jnevro2019119051154-30","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31825d6c25"},{"key":"key-10.17116\/jnevro2019119051154-31","unstructured":"EMEA. Questions and answers on recommendation for refusal of marketing authorisation for Valdoxan\/Thymanax. 2006."},{"key":"key-10.17116\/jnevro2019119051154-32","unstructured":"EMEA.CHMP assessment report for valdoxan. 2008. Accessed May 5th. 2014. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/000915\/WC500046226.pdf"},{"key":"key-10.17116\/jnevro2019119051154-33","unstructured":"EMA Post authorisation opinion regarding Agomelatine. Journal name. 2013."},{"key":"key-10.17116\/jnevro2019119051154-34","doi-asserted-by":"publisher","DOI":"10.2165\/11593960-000000000-00000"},{"key":"key-10.17116\/jnevro2019119051154-35","doi-asserted-by":"publisher","DOI":"10.2174\/157015910792246227"},{"key":"key-10.17116\/jnevro2019119051154-36","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832a8eb2"},{"key":"key-10.17116\/jnevro2019119051154-37","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.06.003"},{"key":"key-10.17116\/jnevro2019119051154-38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa065779"},{"key":"key-10.17116\/jnevro2019119051154-39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"key-10.17116\/jnevro2019119051154-40","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32835b0814"},{"key":"key-10.17116\/jnevro2019119051154-41","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000679"},{"key":"key-10.17116\/jnevro2019119051154-42","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1287778"},{"key":"key-10.17116\/jnevro2019119051154-43","unstructured":"Baryl'nik YuB, Filippova NV, Trayber LV. Modern approaches to the synchronization of circadian rhythms during depression. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;11:124-128. (In Russ.)"},{"key":"key-10.17116\/jnevro2019119051154-44","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201611611126-34"},{"key":"key-10.17116\/jnevro2019119051154-45","doi-asserted-by":"publisher","DOI":"10.1007\/s11055-018-0572-x"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T13:27:40Z","timestamp":1563370060000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2019\/5\/downloads\/ru\/1199772982019051154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["jnevro2019119051154"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2019119051154","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}